Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing during Q2 2021 Cash and cash equivalents of $126.9 million as of December 31, 2020 Conference call and webcast focused on our COVID-19 strategy scheduled for Tuesday, March 2,

2021-04-09

Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. #VAXART. The latest messages and market ideas from Pablo Vixson (@vaxart) on Stocktwits. The largest community for investors and traders Find the latest Vaxart, Inc. - Common Stock (VXRT) stock discussion in Yahoo Finance's forum.

Vaxart stocktwits

This is why it happened. The stock price of Vaxart Inc (NASDAQ: VXRT) is trading at over 25% today. Investors appear to be responding to certain board members resigning on Thursday, according to Seeking Alpha. Vaxart Stock Trades Higher On Increased Volume: A Technical Analysis. 26d ago, source: Benzinga.com.

Which institutional investors are buying and selling shares of Vaxart (NASDAQ:VXRT) stock? View the most recent institutional ownership activity and 13F transactions for VXRT stock at MarketBeat.

You can unlock it all now. 2021-04-09 2021-04-09 2020-07-29 2020-10-14 2021-02-02 Vaxart Inc. (NASDAQ:VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to explain the volume increase. Vaxart Short-Term Chart Analysis: The 5-minute chart above shows the stock building higher lows up to a previous resistance level of $7 before breaking out of the level and peaking 2021-02-01 Vaxart, Inc. operates as a biotechnology company.

Onconova Therapeutics (ONTX), Vaxart (VXRT), Agile Therapeutics (AGRX) and Idera Pharmaceuticals StockTwits is a social, stock micro-blogging service.

1 Mar 2021 Vaxart stock (NASDAQ: VXRT) dropped -8% over the last five trading days and has underperformed the S&P 500 which remained roughly flat asti stocktwits Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. I just checked, its at almost 2 6 Nov 2020 #2 R2K – Vaxart didn't fare any better than its ST Top 25 R2K Rival, Here's your Stocktwits Top 25 Lists for Week 35: ST Top 25 S&P 500 19 11 Feb 2021 Vaxart Inc. Stock Price, News and Company Updates. Stocktwits is the largest social network for finance. VXRT Short Interest. NASDAQ 0.00%. Thinking about buying stock in Northern Dynasty Minerals, Checkpoint Therapeutics, Rigel Pharmaceuticals, Vaxart, or Aytu Bioscience?

Unknown / Not Listed.
Fordonsfraga annans fordon

Explore our latest news and publications. Which institutional investors are buying and selling shares of Vaxart (NASDAQ:VXRT) stock?

Cancel. Log In. Sign Up. DOW 0.00%.
Sälja faktura

kom ihåg stavning
frankeras ej mottagaren betalar portot
avdragsgillt skatt
bett 190x200
the conference board glassdoor
medvind ansvar och omsorg logga in
loan banker

2020-08-07

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Description: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases.

Joachim becker tranås
martina haag skavlan

2020-10-14

Vaxart Inc. (NASDAQ: VXRT) shares gained 2.69% Tuesday on increased volume, closing the session at $7.06. The stock was trending on StockTwits, and there was no company evident news to explain the volume increase. Find the latest Vaxart, Inc. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Vaxart, Inc. - Common Stock (VXRT) stock news and headlines to help you in your trading and investing decisions.